ABSTRACT: It is unclear how sublethal hypoxia affects lung development. To investigate the effects of chronic hypoxia on postnatal lung remodeling, we treated neonatal rats with FIO 2 of 0.12 for 10 d and analyzed lung development by morphometry and gene expression by DNA microarray. Our results showed the neonatal rats exposed to hypoxia reduced body weight by 42% and wet lung weight by 32% compared with the neonatal rats exposed to normoxia. In the neonatal rats exposed to hypoxia, the radial alveolar counts were decreased to 5.6 from 7.9 and the mean linear intercepts were increased to 56.5 m from 38.2 m. In DNA microarray analysis, approximately half of probed genes were unknown. Chronic hypoxia significantly regulated expression of genes that are involved in pathogenesis of pulmonary hypertension and postnatal lung remodeling. Chemokine ligand 12, jagged 2 were among those upregulated; c-kit, ephrin A1, and Hif-2␣ were among those downregulated. The altered expression of those genes was correlated with the lung development and remodeling. (Pediatr Res 64: 56-62, 2008) 
D
evelopment of the immature lung with a saccular morphology and limited gas exchange area to an architecturally mature lung with large internal surface area takes many steps: thinning of alveolar septal walls, concomitant growth of the capillary network, and extensive subdivision of gas exchange or acinar units. Alveolar septation apparently occurs as secondary crests extend from primary alveolar walls and the alveolar capillary network becomes more complex (1, 2) . Vascular development occurs by means of vasculogenesis, the development of blood vessels from the differentiating of angioblasts in the mesoderm, and the more clinically relevant process of angiogenesis, the sprouting of blood vessels from existing vessels. Preacinar pulmonary arteries supplied by the right heart grow with the airways into the intraacinar region infused with the peripheral microvasculature that has arisen there by means of vasculogenesis (3) . Angiogenesis is orchestrated and mediated by interaction between and among protein ligands and their cognate receptors to induce endothelial cell proliferation, migration, differentiation, and organization as well as remodeling into vascular networks (4, 5) . The requirement of normal pulmonary vascularization for alveolarization implies an interrelationship between capillary invasion and alveolar septation (6) . Factors that interfere with this process may be sublethal in nature but result in long-term pulmonary functional limitations (7) .
Pulmonary vascular development proceeds under hypoxic conditions in the fetus. Hypoxia is known to modulate the expression of angiogenic factors and potentially to affect lung microvascular development and lung morphogenesis (8) . However, the impact on microvascular alterations at the level of these angiogenic factors by changes in oxygen tension has not been thoroughly studied.
There are clinical implications to this issue. In the clinical disorder, bronchopulmonary dysplasia (BPD), regional alveolar hypoxia likely develops in association with the distal airway heterogeneous changes previously described (9) . Maldistribution of ventilation may develop especially during the early phases of BPD when either no increase or when only modest increases in FIO 2 are administered. Alveolar hypoxia then would develop in areas with very low ventilationperfusion ratios. Separate from the postnatal problems arising in BPD, sustained altitude associated hypoxia has been associated with reduced gas exchange efficiency in otherwise healthy term infants (10) .
To evaluate the effects of alveolar hypoxia on developing lung, we used the rat pup, whose saccular and alveolar stages of development occur postnatally during the first 2 wks, compared with prenatally in humans (2) . We sought to relate morphometric findings of microvascular and septal development to alterations in lung expression of vasoactive substances.
METHODS
Animal exposure to oxygen. All experiments were conducted by protocols approved by the Institutional Animal Care and Use Committee at the University of Kansas School of Medicine. Three treatment groups of pups were created: pups from dams fed ad libitum and maintained in normoxia (room air, n ϭ 11), pups exposed to hypoxia (FIO 2 ϭ 0.12) from day 4 to day 14 of life (n ϭ 11), whose dams were fed ad libitum; and pups maintained in normoxia, whose dams were pair-fed based on the amount of food consumed by their hypoxia-exposed counterparts (n ϭ 11). Normoxia and hypoxia dams in these groups were rotated every 24 h during hypoxia exposure.
Total RNA preparation from tissue. Pups killed on day 10 of exposure (14 d of life) had lung tissue harvested. Total RNA was extracted with TRIzol reagent from Invitrogen according to the manufacturer's protocol. One microgram of total RNA was used for the first strand cDNA synthesis using oligo d(T) primers according to the first strand cDNA synthesis kit protocol from Invitrogen. Before cDNA synthesis, total RNA was treated with RNase-free DNase I to eliminate any DNA contamination; nonreverse-transcription (without adding reverse transcriptase in cDNA synthesis) samples were also included as negative controls. The resulting cDNAs were then used for real-time PCR. The primers used for Jagged 2 were, sense 5Ј-TGCACTGGTAGAGTACGTCCT-TGT-3Ј and antisense, 5Ј-AACAA CCAGTGGGCTCCGCTCAAT-3Ј; for CXCL12: sense, 5Ј-GCCAACGTCAAACATCTGAA-3Ј, antisense: 5Ј-TAATTTCGGGTCAATGCACA-3Ј. The real-time PCR was run with SYBR green using two-step PCR protocol (95°C for 3 min; 95°C for 10 s, and 55°C, 45 s for 40 cycles) with melting curve. The threshold cycle (Ct) was used to quantify the sample mRNA levels with housekeeping gene ␤-actin normalization.
Immunohistochemistry. Pups were killed at exposure day 0 (baseline) and exposure days 3 and 10. Lungs were tracheally-perfused and fixed at 24 cm H 2 O pressure for 24 h, with 4% buffered formaldehyde solution for histologic studies. The lungs were then processed for histology by cutting into blocks at right angles to the main bronchus. Tissue blocks were embedded in paraffin and sectioned at a thickness of 5 m. Samples were mounted on positively charged glass microscope slides and kept in a 60°C oven overnight, then deparaffinized, and rehydrated. Staining was enhanced by steaming slides in target retrieval solution (DAKO, Carpinteria, CA) for 20 min. After incubation with blocking serum (DAKO, Carpinteria, CA) for 10 min, slides were incubated with mouse anti-rat monoclonal PECAM-1 (CD31) antibody for 1 h (Serotec, Kidlington, Oxford, UK). Sections were then immunohistochemically stained using a modified avidin-biotin-peroxidase method (Vectastain ABC Elite Kit, Vector Laboratories, Burlingame, CA). Antigenic sites were visualized by addition of the chromogen 3,3Ј diaminobenzidine. Slides were counterstained with Harris hematoxylin (Fisher HealthCare, Houston, TX). Negative control slides were stained using the same procedure, omitting the primary antibody.
Western blotting analysis. Antibodies were purchased from Santa Cruz, CA and used according to manufacturer's instructions. Lungs were homogenized in RIPA buffer containing PBS, 0.1% SDS, 1% Igepal CA-630 (Sigma Chemical Co., St. Louis, MO), and 0.5% sodium deoxycholate. At the time of use, the following inhibitors were used in per gram tissue: 100 g/mL PMSF, 30 M Aprotinin (Sigma Chemical Co., St. Louis, MO), and 1 mM sodium orthovanadate. The homogenate was centrifuged at 15,000g at 4°C for 20 min. Protein was measured using bicinchoninic acid protein assay kit (Sigma Chemical Co., St. Louis, MO) and then 60 g of protein/lane was applied on a 10% Bis-Tris gel (Invitrogen, Carlsbad, CA). Protein was transferred to a nitrocellulose membrane. The membrane was incubated for one hour at room temperature with 5% nonfat milk in PBST (0.1% Tween-20 in PBS) to block nonspecific binding. The membrane was immunoblotted with the primary antibody at 4°C overnight, followed by three 5-min washes with PBST and then incubated with horseradish peroxidase-conjugated secondary antibody. Detection was conducted by an enhanced chemiluminescent technique (Santa Cruz, CA). The signals on autoradiogram were analyzed with Image software (Alpha Innotech, Sunnyvale, CA) and normalized by ␤-actin in the same sample.
Morphometric analysis. Radial alveolar counts (RAC) were measured as previously described (11, 12) , from the center of a bronchiole lined by epithelium in one part of the wall. A perpendicular line was drawn using image analysis to the nearest connective tissue septum or lung pleural surface, and the number of alveoli cut by the line was counted. The radial alveolar count was measured for every bronchiole on a slide and an average radial alveolar count for the slide was calculated. All analyses were performed without knowledge of the exposure group.
Mean linear intercepts (Lm) were measured using crossed hairlines of known length (13) . Fourteen consecutive parenchymal fields from each lung were examined at ϫ200 magnification, on 5-m sections from the left lower lobe.
Using ANALYSIS Image Analysis (Soft Imaging Software, Lakewood, CO), the volume density of PECAM-1 stained tissue (V V PECAM ) per parenchyma was determined in 14-d-old (day 10 of treatment) rat lungs. Parenchyma was defined as alveolar ducts, alveoli, saccules, their air spaces, and septa. Fifteen fields per animal were measured and averaged to obtain V V PECAM .
DNA microarray analysis. Experimental design of the microarray analysis consists of three technical replicates for control and three replicates for the hypoxia group. We used Affymetrix Rat 230 v.2.0 high density GeneChip and scanned with a GeneChip 3000 High-resolution Scanner (Affymetrix, Santa Clara, CA). This array represents about 31,000 probe sets for gene expression level analysis of over 30,000 transcripts and variants that correspond to over 28,000 well-substantiated rat genes. The initial data captured by Affymetrix GeneChip Operating Software (GCOS) resulted in a single raw value related to each probe set based on the mean of differences between the intensity of hybridization for each perfect match and the mismatch features for a specific transcript. Experimental data set was exported via Data Transfer Tool into the library data file by the GCOS software. Data Mining Tool components were used to process the initial data quality control assessment and to create sets of expressed probes. Total set of 31,099 probes for this particular rat genome was divided into "present," "marginal," and "absent" subsets based on calculated probe detection p-value. Probes present in at least two microarray chips out of three in treatment vs. control were used for evaluation of upregulated genes, whereas for downregulated genes probes present in two of three control arrays facilitated the base for comparison. Signal intensities for individual probe sets in the treatment and control triplicates were subsequently compared statistically with significant differences at p Յ 0.05. GeneChip data sets from GCOS were transferred into text file inputs for GeneSpring software (Agilent Technologies, Silicon Genetics, Redwood City, CA), normalized per chip and gene and ranked according to fold change for treatment vs. control signal intensities. GeneSpring software was also used for graphical interpretation, gene annotation and gene ontologies for biologic processes, molecular functions, and cellular components.
Statistical analysis. The results are expressed as the mean Ϯ SEM of data obtained from two or more experiments; or where appropriate, as mean Ϯ SD. Paired or unpaired t tests were used as appropriate for the continuous data. A value of p Ͻ 0.05 was considered significant.
RESULTS
Chronic hypoxia exposure lowers the body weight and lung wet weight of the newborn rats. Newborn rats exposed to hypoxia (FIO 2 of 0.12) from days 4 to 14 showed a significant body and lung wet weight reduction. During 10-d treatment, body weight of the newborn rats breathing 12% oxygen decreased to 15.7 g, 42% reduction, compared with that of the newborn rats breathing room air (normoxia) with either ad libitum (27 g) or limited fed (24 g) (n ϭ 11, p Ͻ 0.002). The lung wet weight of the newborn rats breathing 12% oxygen declined to 0.28 g, 32% reduction, compared with that of the newborn rats breathing room air (normoxia) with ad libitum (0.41 g) or limited fed (0.41 g) ( Table 1 ; n ϭ 11, p Ͻ 0.001). Lung weight to body weight ratios for each group are shown and demonstrate that hypoxic exposure reduced overall body weight proportional to lung weight (Table 1) .
Chronic hypoxia exposure impairs alveolar formation of the newborn rats. The newborn rats exposed to 10-d hypoxia showed a significant RAC reduction. It was decreased to 5.6 from 7.9 or 7.8 compared with the newborn rats exposed to normoxia with ad libitum or limited fed (Table 2 ; n ϭ 11, p Ͻ 0.002). The Lm was increased in the neonatal rats exposed to hypoxia compared with the neonatal rats exposed to normoxia. Lm was significantly increased to 56.5 m from 38.2 m after 10-d hypoxia exposure ( Fig. 1 ; p Ͻ 0.05, n ϭ 3-4). No changes were found after 3 d exposure to hypoxia. Lung histology analyses showed a homogenous alveolar formation The body weight, lung wet weight, and lung weight to body weight ratio of the neonatal rats were assessed after 10-d exposure to normoxia (21% O 2 ) or hypoxia (12% O 2 ).
* p Ͻ 0.001 compared with normoxia groups.
in the newborn rats treated with normoxia with ad libitum or limited fed ( Fig. 2A) . However, the alveolar formation was reduced in the newborn rats treated with hypoxia and there were fewer and larger alveoli in the hypoxia-treated lungs compared with normoxia-treated lungs (Fig. 2B) . Chronic hypoxia exposure impairs pulmonary vascularization of the newborn rats. Pups exposed to 10-d hypoxia showed a significant PECAM staining reduction. It was significantly decreased to 2.3% from 4.4% compared with the newborn rats exposed to normoxia with ad libitum ( Fig. 3 ; n ϭ 2-4, p Ͻ 0.005).
Chronic hypoxia exposure alters gene expression in the newborn rat lungs. Upregulated genes after chronic hypoxia in the newborn rat lungs are summarized in Table 3 and downregulated genes are summarized in Table 4 . They represent only significantly upregulated or downregulated genes (t test p-value Ͻ0.005) with the fold change exceeding 2.0. Because we have three technical replicates for each, treatment, and control, the fold change was calculated from the average signals for treatment and control. Our selection is only on genes present (detection p-value Ͻ0.05) in at least two of the three replicates. The genes are then clustered in different subgroups based the gene annotation and gene ontology. Among those significantly differentially expressed genes, approximately half of those genes were unknown. Chronic hypoxia exposure of the neonatal rat lungs significantly upregulated 66 genes with known functions (Table 3) . These genes participate in biologic process and molecular function in almost every cellular compartment. Neurotrophic tyrosine kinase, receptor, type 2, chemokine (C-X-C motif) ligand 12, jagged 2 and peroxiredoxin 2 were among those upregulated. The upregulation of those genes suggested that chronic hypoxia increased cellular metabolism, induced inflammation, reduced antioxidant capacity, and interrupted lung development.
The 56 downregulated genes with known functions were likely involved in pathogenesis of pulmonary hypertension, angiogenesis, and changes in extracellular matrix (Table 4) . c-kit receptor tyrosine kinase, aldehyde dehydrogenase family 1, phosphatidylinositol 3-kinase, catalytic, alpha polypeptide, ephrin A1, and endothelial PAS domain protein 1 (Hif-2␣) were among those downregulated, indicating that chronic hypoxia induced pulmonary hypertension, decreased pulmonary angiogenesis, and induced pulmonary cell remodeling.
Expressions of toll-like receptors (TLR) genes TLR2, TLR4, and nitric oxide synthase 1, 2, 3 genes were altered less than 2-fold.
Validated gene expression related to pulmonary vascularization and alveolarization. We performed real-time PCR and Western blotting analysis to validate CXCL12, jagged2, Hif2␣, and c-Kit expression in the neonatal rat lungs exposed to hypoxia for 0, 3, and 10 d. CXCL12 gene expression was increased by 1.8-fold after 10-d hypoxia exposure compared with normoxia exposure (Fig. 4A) . Jagged 2 gene expression was increased by 1.8 and 2.2-fold after 3-and 10-d hypoxia exposure compared with normoxia exposure (Fig. 4B) . Increased CXCL12 and Jagged 2 gene expression after hypoxia exposure was negatively correlated with the development of the neonatal lungs. Western blotting showed Hif-2␣ was decreased by 2-fold after 10 d hypoxia exposure (Fig. 4C and E) and c-Kit was decreased by 2-fold after 10-d hypoxia exposure (Fig. 4D and F), which were consistent with the gene expression data from Affymatrix DNA microarray. The increased expression of CXCL12 and jagged 2 and decreased expression of Hif-2␣ and c-Kit were correlated with the reduction of alveolar formation during chronic hypoxia exposure.
DISCUSSION
In this study, we analyzed differential gene expression and distal lung development after FIO 2 of 0.12 exposure from day 4 to day 14. Hypoxia in the dose and duration used impaired alveolar formation and reduced body weight and lung wet weight during the secondary septation period. Hypoxic exposure increased gene expression of Notch signaling such as jagged 2, and antioxidants such as heat shock protein 70 and peroxiredoxin 2; decreased gene expression of ephrin A1 and Hif-2␣ that are implicated in vascularization. Real-time PCR and Western blotting confirmed that downregulation of Hif-2␣ and c-Kit, and upregulation of CXCL12 and jagged 2 are correlated with impairment of alveolar formation after chronic hypoxia in the neonatal rat lungs.
Chronic hypoxia can impair pulmonary vascularization and alveolar formation in neonatal rats and humans (14, 15) . Alveolar hypoxia in this model reduced pulmonary vessel density, RAC and increased mean Lm. The pups demonstrated fewer and larger alveoli. In addition, it significantly impeded pulmonary vascularization as assessed by decreased vessel density. Our findings suggest that there was diminished secondary septation. Lung development in the first 2 wks of life is largely dependent on secondary septation (2, 16, 17) . However, it is unclear how hypoxia affects the secondary septation. To help clarify this process, we performed DNA array analysis and probed more than 2800 genes. Among those significantly differentially expressed genes, approximately half of those genes were unknown. Chronic hypoxia in the neonatal rat lung significantly upregulated and downregulated genes related to pathogenesis of pulmonary hypertension and vascularization.
For example, jagged 2, a ligand of Notch receptors, was significantly increased during hypoxia exposure, suggesting that Notch signaling pathway may be dysregulated in the newborn rats exposed to chronic hypoxia. The Notch signaling pathway plays an important role in the regulation of arterialvenous differentiation. Jagged 2 is expressed in endothelial cells in developing lungs (18, 19) . The Notch ligand negatively regulated vascularization during development and interruption of Notch signaling increases number of lung buds and branching morphogenesis, although the exact role of Jagged 2 in the developing lungs has not been clearly defined (20 -22) . CXCL12 (also known as stromal cell-derived factor-1) and its receptor, CXCR4, play important roles in ischemic tissue repair, progenitor cell mobilization, and neovascularization during hypoxia exposure (23, 24) . We found that CXCL12 was significantly elevated in the hypoxia-exposed lungs, which indicated that CXCL12 might participate in pulmonary remodeling after hypoxia. The downregulation of c-Kit, a transmembrane tyrosine kinase receptor for stem-cell factor, may reflect the decreasing mobilization of c-Kit positive cells from the bone marrow to lung after prolonged hypoxia. Recent data have suggested that c-kit positive cells could differentiate into endothelial cells and could be involved in the hypoxia-induced remodeled pulmonary artery vessel wall (25) .
The finding of decreased Hif 2␣ expression was unexpected, but it has been reported that chronic hypoxia could reduce gene expression that Hif regulates (26) . Chronic hypoxia also altered gene expression in inflammation, oxidative stress, and cell survival pathways, suggesting that multiple factors and pathways are involved in postnatal lung remodeling during chronic hypoxia. Genes participating in the regulation of TLR were altered by Ͻ2-fold. This finding was of importance, as relative TLR4 deficiency has been shown to induce susceptibility to a different model of lung injury (27) . We used a conservative cutoff of 2-fold gene alteration as a criterion in the gene expression analysis and examined one relatively late time point, hypoxia for 10 d. Additional gene upregulation or downregulation might have been found if we have looked at the early time points such as hypoxia for 3 d.
Several features of the model used in these experiments need to be discussed. Animals were exposed to FIO 2 ϭ 0.12 beginning on day 4 and continuing to day 14 of life. We chose this model after pilot work with exposure to FIO 2 ϭ 0.10 resulted in unacceptably high mortality at and beyond 7 d of exposure. Also, infants born at an altitude at which the FIO 2 is approximately 0.12 (28) demonstrate impaired gas exchange (10) . With FIO 2 ϭ 0.12 there were no unplanned deaths of the exposure pups. We waited 4 d after birth to initiate hypoxic exposure to mimic the contemporary clinical course of BPD. There is often a "honeymoon" of up to one to 2 wks during which supplemental FIO 2 needs and ventilatory support are minimal. Our findings, obtained after a short waiting period, demonstrate that sublethal alveolar hypoxia still profoundly disrupts pulmonary development, and that histologically, 3 d exposure is insufficient to produce these changes. There are obvious limitations in comparing carefully controlled administration of O 2 and resultant perturbations in lung development conducted on small mammal species to human studies, but this brief period of normoxia followed by 10 d breathing FIO 2 of 0.12 was associated with histopathological and transcriptive changes. We cannot speculate as to whether hypoxia beginning at day 0, or alternatively, waiting until day 7 would have exacerbated or minimized these findings.
There are several unique features to the study. To our knowledge, ours is the first report using the rat-specific wide array gene chip analysis for identifying rat lung gene expression profiles following alveolar hypoxic exposure. Several previously uncharacterized gene expression patterns were identified and potentially offer important therapeutic targets. We sought to identify correlations between alveolar and microvascular abnormal development and up-or downregulation of key genes in the rat lung known or suspected to be associated with vascular/airway development. Other methodological factors of note included the use of a concurrent limited feeding group to minimize, but likely not eliminate, the effect of reduced nutritional intake by the rat pups during their hypoxic exposure. Use of a pair fed normoxia comparison group increases the likelihood that the pulmonary findings in the chronic hypoxia group were caused directly by the effects of alveolar hypoxia and not by secondary effects of nutrient intake.
In summary, we showed that chronic hypoxia interrupted lung development, likely inducing permanent structural alterations. The corresponding altered gene expression pattern indicates that multiple pathways were involved.
